Shares in international private healthcare group Mediclinic International plummeted this morning (17 October) after the London-listed company flagged an 8% drop in EBITDA to £214m for the first half of 2018. The Group, which has a 29.9% stake in Spire Healthcare, attributed to its lacklustre results to underperformance in its Swiss division, where it said regulatory…